---
document_datetime: 2023-09-21 19:17:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ibandronic-acid-teva-epar-all-authorised-presentations_en.pdf
document_name: ibandronic-acid-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4152113
conversion_datetime: 2025-12-29 20:07:07.445582
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Name                 | Strength   | Pharmaceutical     | Route of   | Packaging                   | Package size   |
|-----------------|----------------------|------------|--------------------|------------|-----------------------------|----------------|
| EU/1/10/642/001 | Ibandronic Acid Teva | 50 mg      | Film-coated tablet | Oral use   | blister (PVC/Aclar/PVC-alu) | 28 tablets     |
| EU/1/10/642/002 | Ibandronic Acid Teva | 50 mg      | Film-coated tablet | Oral use   | blister (PVC/Aclar/PVC-alu) | 84 tablets     |
| EU/1/10/642/003 | Ibandronic Acid Teva | 150 mg     | Film-coated tablet | Oral use   | blister (PVC/Aclar/PVC-alu) | 1 tablet       |
| EU/1/10/642/004 | Ibandronic Acid Teva | 150 mg     | Film-coated tablet | Oral use   | blister (PVC/Aclar/PVC-alu) | 3 tablets      |